ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Nephrology

Top Nephrology Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KHOSROW DAVACHI MD

Nephrology

8,951

$531K

353
207 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$59
Average prescription price

Avg: $135

ROBERT WELIK MD PA

Nephrology

8,340

$1.01M

407
314 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$121
Average prescription price

Avg: $135

ONEY ZUNIGA MD

Nephrology

8,206

$648K

223
170 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 31%

$79
Average prescription price

Avg: $135

ELI ROZA MD

Nephrology

5,442

$811K

265
180 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 31%

$149
Average prescription price

Avg: $135

CHARLES CANGRO MD

Nephrology

5,418

$516K

489
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 31%

$95
Average prescription price

Avg: $135

VICTOR ONYEJIAKA MD

Nephrology

5,052

$302K

110
76 are 65+

25%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 31%

$60
Average prescription price

Avg: $135

RAYMOND BASS M.D.

Nephrology

4,629

$396K

350
244 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$86
Average prescription price

Avg: $135

JOHN DALTON M.D.

Nephrology

4,378

$277K

169
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 31%

$63
Average prescription price

Avg: $135

FARZAD ASSAR M.D.

Nephrology

4,205

$338K

151
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$80
Average prescription price

Avg: $135

BEJE THOMAS M.D.

Nephrology

3,743

$338K

393
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 31%

$90
Average prescription price

Avg: $135

WILLIAM JOHNSON M.D.,

Nephrology

3,458

$445K

304
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$129
Average prescription price

Avg: $135

MARY BEHRENS M.D.

Nephrology

3,059

$459K

150
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 31%

$150
Average prescription price

Avg: $135

BARRY HECHT M.D.

Nephrology

2,927

$261K

227
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$89
Average prescription price

Avg: $135

BABAK RAZI MD

Nephrology

2,925

$542K

149
58 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$185
Average prescription price

Avg: $135

ANISH HINDUJA MD

Nephrology

2,701

$316K

183
126 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 31%

$117
Average prescription price

Avg: $135

PAUL LIGHT M.D.

Nephrology

2,672

$480K

115
33 are 65+

31%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 31%

$180
Average prescription price

Avg: $135

ANDREW NOWAKOWSKI M.D.

Nephrology

2,661

$267K

224
143 are 65+

20%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$100
Average prescription price

Avg: $135

PROMOD DUGGAL M.D.

Nephrology

2,495

$441K

205
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 31%

$177
Average prescription price

Avg: $135

ROBERT GREENWELL M.D.

Nephrology

2,469

$516K

183
83 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$209
Average prescription price

Avg: $135

JEREMY YOSPIN M.D.

Nephrology

2,293

$222K

240
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 31%

$97
Average prescription price

Avg: $135

KENNETH YIM M.D.

Nephrology

2,261

$387K

148
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 31%

$171
Average prescription price

Avg: $135

PHILIP SCHWARTZ M.D.

Nephrology

2,242

$280K

199
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 31%

$125
Average prescription price

Avg: $135

LINDA FREILICH M.D., P.A.

Nephrology

2,215

$234K

182
93 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$105
Average prescription price

Avg: $135

BUARI OSMAN MD

Nephrology

2,145

$424K

180
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$197
Average prescription price

Avg: $135

DONNA HANES M.D.

Nephrology

2,071

$254K

91
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 31%

$123
Average prescription price

Avg: $135

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank